Plano Pharmaceuticals, a specialty injectable and blow-fill-seal (BFS) pharmaceutical company, is pleased to announce the expansion of our manufacturing capabilities with the establishment of a new facility in the European Union (EU).
This strategic move further strengthens our global presence and enables us to meet the increasing demand for our high-quality generic and specialty injectable products. The new EU facility will work in tandem with our existing manufacturing sites, including those in the US, and will enhance our capacity to serve healthcare providers and patients across the EU market.
Plano Pharmaceuticals' commitment to manufacturing excellence remains unwavering. We have partnered with top-tier Contract Manufacturing Organizations (CMOs) to ensure the highest standards of quality, efficiency, and regulatory compliance. With our expanded manufacturing capabilities, we are well-positioned to deliver reliable and innovative pharmaceutical solutions to healthcare professionals and patients in the EU and beyond.
Comments